Royce & Associates LP decreased its stake in Elizabeth Arden Inc. (NASDAQ:RDEN) by 94.4% during the second quarter, Holdings Channel reports. The firm owned 70,000 shares of the company’s stock after selling 1,170,894 shares during the period. Royce & Associates LP owned 0.23% of Elizabeth Arden worth $963,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in RDEN. Sphinx Trading LP purchased a new position in shares of Elizabeth Arden during the second quarter valued at about $110,000. Quantitative Systematic Strategies LLC bought a new stake in Elizabeth Arden during the second quarter worth about $176,000. BlackRock Group LTD boosted its stake in Elizabeth Arden by 15.5% in the first quarter. BlackRock Group LTD now owns 22,900 shares of the company’s stock worth $188,000 after buying an additional 3,065 shares during the last quarter. State Board of Administration of Florida Retirement System boosted its stake in Elizabeth Arden by 6.4% in the second quarter. State Board of Administration of Florida Retirement System now owns 24,969 shares of the company’s stock worth $344,000 after buying an additional 1,491 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. bought a new stake in Elizabeth Arden during the first quarter worth about $211,000. Hedge funds and other institutional investors own 70.70% of the company’s stock.

Shares of Elizabeth Arden Inc. (NASDAQ:RDEN) remained flat at $13.98 on Tuesday. The firm’s 50-day moving average is $13.93 and its 200 day moving average is $10.50. Elizabeth Arden Inc. has a 52 week low of $5.02 and a 52 week high of $14.14.

Elizabeth Arden (NASDAQ:RDEN) last issued its quarterly earnings results on Wednesday, August 10th. The company reported ($0.58) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.78) by $0.20. The company had revenue of $192.70 million for the quarter, compared to the consensus estimate of $193.75 million. Elizabeth Arden had a negative return on equity of 38.72% and a negative net margin of 7.43%. On average, equities research analysts predict that Elizabeth Arden Inc. will post ($0.49) EPS for the current fiscal year.

A number of equities research analysts have issued reports on RDEN shares. Zacks Investment Research upgraded Elizabeth Arden from a “hold” rating to a “buy” rating and set a $16.00 target price on the stock in a research note on Tuesday, August 16th. Imperial Capital reiterated an “outperform” rating and issued a $14.00 target price on shares of Elizabeth Arden in a research note on Wednesday, June 8th. Finally, B. Riley reiterated a “neutral” rating and issued a $14.00 target price on shares of Elizabeth Arden in a research note on Wednesday, June 22nd.

About Elizabeth Arden

Elizabeth Arden, Inc is a global beauty products company with a portfolio of fragrance, skin care and cosmetics brands. The Company’s product portfolio includes Elizabeth Arden Brand, such as the Elizabeth Arden skin care brands (Visible Difference, Ceramide, Prevage, Eight Hour Cream, Superstart and Elizabeth Arden Pro), Elizabeth Arden branded lipstick, foundation and other color cosmetics products and Elizabeth Arden fragrances (Red Door, 5th Avenue, Elizabeth Arden Green Tea and UNTOLD); designer fragrances, which include Juicy Couture, John Varvatos, and Wildfox Couture; Heritage Fragrances, such as Curve, Elizabeth Taylor, Britney Spears, Halston, Ed Hardy, Geoffrey Beene, Alfred Sung, Giorgio Beverly Hills, Lucky, PS Fine Cologne, White Shoulders, BCBGMAXAZRIA, Rocawear and Jennifer Aniston, and celebrity fragrances, which include the fragrance brands of Justin Bieber, Mariah Carey, Nicki Minaj and Taylor Swift.

5 Day Chart for NASDAQ:RDEN

Want to see what other hedge funds are holding RDEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elizabeth Arden Inc. (NASDAQ:RDEN).

Receive News & Ratings for Elizabeth Arden Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elizabeth Arden Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.